[1]
2021. Efficacy and Safety of Ruxolitinib Cream for the Treatment of Atopic Dermatitis: Pooled Analysis of Two Phase 3, Randomized, Double-Blind Studies. SKIN The Journal of Cutaneous Medicine. 5, 1 (Jan. 2021), s8. DOI:https://doi.org/10.25251/skin.5.supp.8.